May Hill Capital
ABBV icon

May Hill Capital’s AbbVie ABBV Stock Holding History

May Hill Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.11M Buy
4,238
+141
+3% +$36.1K 0.22% 78
2026
Q2 		$1.03M Buy
4,097
+266
+7% +$57.2K 0.22% 75
2026
Q1 		$833K Buy
3,831
+526
+16% +$117K 0.21% 78
2025
Q4 		$755K Buy
3,305
+115
+4% +$26.2K 0.2% 80
2025
Q3 		$739K Buy
3,190
+217
+7% +$44.2K 0.22% 74
2025
Q2 		$552K Sell
2,973
-633
-18% -$118K 0.18% 87
2025
Q1 		$756K Buy
3,606
+2
+0.1% +$389 0.29% 60
2024
Q4 		$640K Buy
+3,604
New +$663K 0.25% 61

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

May Hill Capital's ABBV Position: Q3 2026 in Review

May Hill Capital increased its AbbVie (ABBV) stake by 3.4% in Q3 2026, buying an estimated $36.1K and bringing the position to 4,238 shares worth $1.11M. The position accounts for 0.22% of the portfolio, ranked #78.

May Hill Capital first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 2,903 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • May Hill Capital held 4,238 shares of AbbVie worth $1.11M as of Q3 2026.
  • May Hill Capital bought 141 AbbVie shares in Q3 2026, an estimated $36.1K.
  • AbbVie made up 0.22% of May Hill Capital's portfolio in Q3 2026, its #78 holding.
  • May Hill Capital first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 2,903 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on May Hill Capital's 13F filing for Q3 2026, filed 3 Nov 2026.